Chris Impey has received funding from NASA, NSF, Howard Hughes Medical Institute, and the Templeton Foundation. If you look across space with a telescope, you’ll see countless galaxies, most of which ...

Steven Smith looks set to emulate former West Indies batter Shivnarine Chanderpaul by wearing 'eye blacks' on his cheeks during the second Ashes Test at the Gabba. He trialled the anti-glare strips ...

Tourmaline Oil remains a leading Canadian natural gas producer. TRMLF's strong natural gas acreage and profitability drive its production focus. Cash flow remains robust even amid AECO price ...

Beloved around the world in books, cartoon strips, TV series and movies, the Moomins are coming to the big screen. Moomin Characters and Annapurna announced today that they are bringing the creatures ...

"We already see indications of cracks in the standard model." When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Are we living in a simulation? Well ...

Steven Universe creator Rebecca Sugar says she had to fight to get Cartoon Network to allow her to include queer, nonbinary characters Ruby and Sapphire in the beloved animated series. Sugar opened up ...

Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...

BERLIN, Sept 9 (Reuters) - Novartis (NOVN.S), opens new tab will acquire Tourmaline Bio (TRML.O), opens new tab for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion ...

Tourmaline Bio, Inc. (NASDAQ:TRML) shares surged Tuesday after Novartis AG (NYSE:NVS) announced a $1.4 billion acquisition of the U.S.-based biotech, strengthening the Swiss drugmaker’s pipeline of ...

Novartis is paying $1.4 billion to get its hands on Tourmaline Bio and its former Pfizer cardiovascular drug that impressed in a phase 2 study earlier this year. At the center of the deal is ...

Novartis NOVN-0.20%decrease; red down pointing triangle agreed to buy Tourmaline Bio in a roughly $1.4 billion-dollar deal that boosts its cardiovascular drug pipeline with access to the targeted ...